These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2647854)
1. In vitro stimulation of immune spleen cells enhances the number of anti-lipid A-producing hybridomas. Erich T; Dekker B; De Beer M; Torensma R; Verhoef J J Immunol Methods; 1989 Mar; 118(1):17-24. PubMed ID: 2647854 [TBL] [Abstract][Full Text] [Related]
2. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells. Takahashi M; Fuller SA; Hurrell JG J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of lipopolysaccharide mitogenicity with characterized anti-lipid A monoclonal antibodies. Girard R; Chaby R Immunology; 1985 Nov; 56(3):481-7. PubMed ID: 2867028 [TBL] [Abstract][Full Text] [Related]
4. Production of monoclonal antibodies specific for African swine fever virus following in vitro primary immunization of mouse splenocytes in the presence of stimulated T lymphocyte supernatants. Federspiel G; McCullough KC; Kihm U J Immunol Methods; 1991 Dec; 145(1-2):71-81. PubMed ID: 1765668 [TBL] [Abstract][Full Text] [Related]
5. Production of monoclonal antibodies in a mouse model via lipopolysaccharide conjugates with synthetic polymers specific to Salmonella Enteritidis O antigen. Nalbantsoy A; Karaboz I; Gurhan ID Foodborne Pathog Dis; 2010 Dec; 7(12):1521-9. PubMed ID: 20707736 [TBL] [Abstract][Full Text] [Related]
6. Preferential generation of IgG-producing human hybridomas against human tumor cells. Hagiwara H; Nagao J J Immunol Methods; 1990 Dec; 135(1-2):263-71. PubMed ID: 2125620 [TBL] [Abstract][Full Text] [Related]
7. Immortalization of antigen selected B cells. Steenbakkers PG; van Wezenbeek PM; Olijve W J Immunol Methods; 1993 Jul; 163(1):33-40. PubMed ID: 7687638 [TBL] [Abstract][Full Text] [Related]
8. Requirements for the generation of memory B cells in vivo and their subsequent activation in vitro for the production of antigen-specific hybridomas. De Boer M; Ten Voorde GH; Ossendorp FA; Van Duijn G; Tager JM J Immunol Methods; 1988 Oct; 113(1):143-9. PubMed ID: 2459251 [TBL] [Abstract][Full Text] [Related]
9. Increased proportion of antigen-specific antibody-producing hybridomas following an in vitro immunization with in vivo immunized mouse spleen cells. Enriquez FJ; Bradley-Dunlop D; Joens L Hybridoma; 1991 Dec; 10(6):745-51. PubMed ID: 1816073 [TBL] [Abstract][Full Text] [Related]
10. Immunization of normal human splenocytes in vitro to produce human monoclonal antibodies to cellular antigens. Hulette CM; Effros RB; Walford RL Tissue Antigens; 1987 Jul; 30(1):25-33. PubMed ID: 3672490 [TBL] [Abstract][Full Text] [Related]
11. The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation. Rycyzyn MA; Staquet K; Fisher J; Bannish G; Bassiri A; Duchala C; Giles-Komar J Hybridoma (Larchmt); 2008 Feb; 27(1):25-30. PubMed ID: 18294073 [TBL] [Abstract][Full Text] [Related]
12. Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA. Velikovsky CA; Cassataro J; Sanchez M; Fossati CA; Fainboim L; Spitz M J Immunol Methods; 2000 Oct; 244(1-2):1-7. PubMed ID: 11033013 [TBL] [Abstract][Full Text] [Related]
13. In vitro stimulation of presensitized mouse spleen cells with poliovirus type 1, Mahoney, and enhancement of poliovirus-specific hybridomas. Wiegers KJ; Uhlig H; Dernick R J Gen Virol; 1986 Sep; 67 ( Pt 9)():2053-7. PubMed ID: 3018136 [TBL] [Abstract][Full Text] [Related]
14. Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique. Stäuber N; Kihm U; McCullough KC J Immunol Methods; 1993 May; 161(2):157-68. PubMed ID: 8505546 [TBL] [Abstract][Full Text] [Related]
15. Dependence of T-cell-replacing factor and immunogenic dose for the production of monoclonal antibodies using the in vitro immunization technique. Borrebaeck CA Mol Immunol; 1984 Oct; 21(10):841-5. PubMed ID: 6334231 [TBL] [Abstract][Full Text] [Related]
16. The production of hybridomas from the gut associated lymphoid tissue of tumour bearing rats. I. Mesenteric nodes as a source of IgG producing cells. Dean CJ; Styles JM; Gyure LA; Peppard J; Hobbs SM; Jackson E; Hall JG Clin Exp Immunol; 1984 Aug; 57(2):358-64. PubMed ID: 6331924 [TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies produced by human-human hybridomas]. Chida J Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711 [TBL] [Abstract][Full Text] [Related]
18. High frequency production of hybridomas secreting antibodies to cell antigens. Cianfriglia M; Nuti M; Turchi V; Barca S; Tombesi M; Morrone S; Cenciarelli C; Natali PG Hybridoma; 1987 Dec; 6(6):673-7. PubMed ID: 3501765 [TBL] [Abstract][Full Text] [Related]
19. Hybridomas producing hemolytic plaques used to study the relationship between monoclonal antibody affinity and the efficiency of plaque inhibition with increasing concentrations of antigen. Bankert RB; Mazzaferro D; Mayers GL Hybridoma; 1981; 1(1):47-58. PubMed ID: 6765319 [TBL] [Abstract][Full Text] [Related]
20. Generation of hybridomas producing human monoclonal antibodies against herpes simplex virus after in vitro stimulation. Masuho Y; Sugano T; Matsumoto Y; Sawada S; Tomibe K Biochem Biophys Res Commun; 1986 Mar; 135(2):495-500. PubMed ID: 3008724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]